Literature DB >> 9160868

The role of Na+-H+ exchange occurring during hypoxia in the genesis of reoxygenation-induced myocardial oedema.

J Inserte1, D Garcia-Dorado, M Ruiz-Meana, J Solares, J Soler.   

Abstract

To investigate the role of Na(+)-H+ exchange occurring during hypoxia in the genesis of reoxygenation-induced myocardial oedema, isolated perfused rat hearts were submitted to 40 min of hypoxia and 90 min of reoxygenation. The influence of three factors on myocardial water content was analysed according to a 2 x 2 x 2 factorial design; the hearts were perfused at either pH = 7.4 or pH = 7.0, with either HCO3- buffer or HCO3(-)-free HEPES buffer, and in half of the experiments the hypoxic buffer contained HOE642 6.7 micromol/l. In an additional group, 160 min of normoxia resulted in no lactate dehydrogenase (LDH) release and in a 35.8% increase in myocardial water, independently of pH and of the presence of HCO3- in the buffer. In hearts perfused at pH = 7.4, reoxygenation induced LDH release which was reduced (P<0.05) by HOE642 by 20.1%, by HCO3(-)-free perfusion by 57.5%, and by the combination of both by 91.2%. Reoxygenation also induced severe myocardial oedema (26.3% increase (P<0.05) respect to normoxia). HOE642 reduced (P<0.05) reoxygenation oedema by 15.7%, HCO3(-)-free perfusion by 8.9%, and the combination of both by 24.6%. The effects of HCO3(-)-free perfusion could be mimicked in HCO3(-)-perfused hearts by blocking Na(+)-HCO3- cotransport with 4-4'-dibenzanidostilbene-2,2'-disulphonic acid (DIDS). The beneficial and additive effects of HOE642 and of HCO3(-)-free perfusion on oedema were not a mere consequence of their protective effects against the oxygen paradox, since they were observed in groups perfused at pH= 7.0, a condition which virtually prevented LDH release without preventing oedema (19.0% increase in myocardial water). Thus, reoxygenation-induced myocardial oedema may occur in the absence of necrosis, and is largely determined by Na+ gain during hypoxia via Na(+)-H+ exchange and Na(+)-HCO3- cotransport.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160868     DOI: 10.1006/jmcc.1996.0352

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  Effect of factor XIII on endothelial barrier function.

Authors:  T Noll; G Wozniak; K McCarson; A Hajimohammad; H J Metzner; J Inserte; W Kummer; F W Hehrlein; H M Piper
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

2.  Optical imaging of mitochondrial function uncovers actively propagating waves of mitochondrial membrane potential collapse across intact heart.

Authors:  Alexander R Lyon; Paul J Joudrey; Dongzhu Jin; Robert D Nass; Miguel A Aon; Brian O'Rourke; Fadi G Akar
Journal:  J Mol Cell Cardiol       Date:  2010-07-16       Impact factor: 5.000

Review 3.  The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure.

Authors:  M Karmazyn; J V Sostaric; X T Gan
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Evaluation of MRI protocols for the assessment of lumbar facet joints after MR-guided focused ultrasound treatment.

Authors:  Roland Krug; Loi Do; Viola Rieke; Mark W Wilson; Maythem Saeed
Journal:  J Ther Ultrasound       Date:  2016-04-06

5.  Measuring Water Distribution in the Heart: Preventing Edema Reduces Ischemia-Reperfusion Injury.

Authors:  Mireia Andrés-Villarreal; Ignasi Barba; Marcos Poncelas; Javier Inserte; José Rodriguez-Palomares; Victor Pineda; David Garcia-Dorado
Journal:  J Am Heart Assoc       Date:  2016-12-17       Impact factor: 5.501

6.  PEDF decreases cardiomyocyte edema during oxygen‑glucose deprivation and recovery via inhibiting lactate accumulation and expression of AQP1.

Authors:  Bing Huang; Haoran Miao; Yanliang Yuan; Fan Qiu; Xiucheng Liu; Zhiwei Liu; Hu Zhang; Qixiang Zhao; Meng Wang; Hongyan Dong; Zhongming Zhang
Journal:  Int J Mol Med       Date:  2019-03-12       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.